Major Vivani Medical Stakeholder Increases Ownership with Fresh Options Grant

Rhea-AI Filing Summary

Vivani Medical (VANI) reported insider trading activity through a Form 4 filing for Director and 10% Owner Gregg Williams. The filing details two significant option-related transactions:

• On June 24, 2025, Williams was granted 35,135 non-qualified stock options with an exercise price of $1.27. These options vest fully on either the first anniversary or next annual stockholder meeting, whichever comes first.
• A correction was made to a previous January 1, 2025 option grant, adjusting the total beneficial ownership from 76,757 to 76,393 options (exercise price $1.16) due to a clerical error. These options vest quarterly.

The transactions reflect standard director compensation practices and demonstrate continued insider equity participation in the company. The filing was signed by Adam Mendelsohn as attorney-in-fact on June 26, 2025.

Insider Trade Summary

2 transactions reported

Mixed 2 txns

Insider Williams Gregg

Role Director, 10% Owner

Type	Security	Shares	Price	Value
Grant/Award	Non-Qualified Stock Option (right to buy)	35,135	$1.27	$45K
Disposition	Non-Qualified Stock Option (right to buy)	364	$1.16	$422.24

Holdings After Transaction: Non-Qualified Stock Option (right to buy) — 35,135 shares (Direct)

Footnotes (1)

1. Annual grant awarded pursuant to the Issuer's Non-Employee Director Compensation Policy. The option vests in total on the earlier of (i) the first anniversary of the grant or (ii) the next annual meeting of stockholders, subject to continued service through such date. Reflects an adjustment to a previously reported amount grant on 01/01/2025 from 76,757 to 76,393 due to a clerical error. The option will vest one-fourth at the end of each calendar quarter following the grant date, subject to continued service through each such date.

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

X

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Williams Gregg

(Last) (First) (Middle)

C/O VIVANI MEDICAL, INC.

1350 S. LOOP ROAD

(Street)

ALAMEDA CA 94502

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Vivani Medical, Inc. [ VANI ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	X	10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
06/24/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Non-Qualified Stock Option (right to buy)	$1.27	06/24/2025		A		35,135		(1)(2)	06/23/2035	Common Stock	35,135(2)	$1.27	35,135(2)	D
Non-Qualified Stock Option (right to buy)	$1.16	01/01/2025		D(3)			364(3)	(4)	12/31/2034	Common Stock	364(3)	$1.16	76,393(3)	D

Explanation of Responses:

1. Annual grant awarded pursuant to the Issuer's Non-Employee Director Compensation Policy.

2. The option vests in total on the earlier of (i) the first anniversary of the grant or (ii) the next annual meeting of stockholders, subject to continued service through such date.

3. Reflects an adjustment to a previously reported amount grant on 01/01/2025 from 76,757 to 76,393 due to a clerical error.

4. The option will vest one-fourth at the end of each calendar quarter following the grant date, subject to continued service through each such date.

Remarks:

Exhibit 24 Power of Attorney

	/s/ Adam Mendelsohn, Attorney-in-fact	06/26/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What stock options did Gregg Williams receive from VANI on June 24, 2025?

Gregg Williams received 35,135 non-qualified stock options with an exercise price of $1.27 per share on June 24, 2025. These options were granted as part of VANI's Non-Employee Director Compensation Policy and will vest in full on either the first anniversary of the grant or the next annual meeting of stockholders, whichever comes first.

What positions does Gregg Williams hold at VANI?

According to the Form 4 filing, Gregg Williams serves as both a Director and a 10% Owner of Vivani Medical, Inc. (VANI).

When do VANI's June 2025 stock options granted to Gregg Williams expire?

The non-qualified stock options granted to Gregg Williams on June 24, 2025, expire on June 23, 2035, giving them a 10-year term from the date of grant.

What correction was made to Gregg Williams' January 2025 VANI stock option grant?

The filing disclosed a correction to Williams' January 1, 2025 stock option grant, adjusting the previously reported amount from 76,757 to 76,393 options (a reduction of 364 options) due to a clerical error. These options have an exercise price of $1.16 per share.

What is the vesting schedule for VANI's January 2025 stock options granted to Gregg Williams?

The January 2025 stock options vest one-fourth at the end of each calendar quarter following the grant date (January 1, 2025), subject to Williams' continued service through each vesting date.